ZAS Corporation proudly launched Uro-Vaxom, an advanced immunotherapeutic solution by OM Pharma, Switzerland, for preventing recurrent urinary tract infections (UTIs). […]
In collaboration with the Nephrology Department at the National Institute of Kidney Diseases & Urology (NIKDU), ZAS Corporation Ltd. hosted
ZAS Corporation proudly participated in the prestigious MOSB Congress 2024, reaffirming its dedication to advancing oncology care in Bangladesh. The
ZAS Corporation was honored to serve as the core sponsor of the 178th World Anesthesia Day celebration, organized by the
We are proud to announce the successful launch of Celltrion’s biosimilar products in Bangladesh, marking a significant milestone in our
ZAS Corporation, in collaboration with the Bangladesh Society of Critical Care Medicine (BSCCM), recently organized a scientific seminar focused on
ZAS Corporation is proud to announce the successful launch of Polymyxin B, a groundbreaking antibiotic from our Critical Care division.
ZAS Corporation Ltd. has pledged its support to the 4th International Scientific Conference of Bangladesh Perinatal Society, reinforcing its dedication
In a groundbreaking collaboration, the Bangladesh Endocrine Society (BES) joined forces with medical experts to conduct a Continuing Medical Education
In a promising stride towards combating respiratory infections, ZAS Corporation Ltd. joined hands with the Bangladesh Lung Foundation to pioneer
